| 河北省1989－2013年HIV/AIDS死亡与HAART关系的分析 |
| |
| 引用本文： | 陈素良,马琳,路新利,李岩,王伟,王莹莹,赵翠英,张玉琪,赵宏儒.河北省1989－2013年HIV/AIDS死亡与HAART关系的分析[J].中华流行病学杂志,2015,36(5):460-464. |
| |
| 作者姓名： | 陈素良 马琳 路新利 李岩 王伟 王莹莹 赵翠英 张玉琪 赵宏儒 |
| |
| 作者单位： | 050021 石家庄, 河北省疾病预防控制中心 河北省医学病毒学重点学科;050021 石家庄, 河北省疾病预防控制中心 河北省医学病毒学重点学科;050021 石家庄, 河北省疾病预防控制中心 河北省医学病毒学重点学科;050021 石家庄, 河北省疾病预防控制中心 河北省医学病毒学重点学科;050021 石家庄, 河北省疾病预防控制中心 河北省医学病毒学重点学科;050021 石家庄, 河北省疾病预防控制中心 河北省医学病毒学重点学科;050021 石家庄, 河北省疾病预防控制中心 河北省医学病毒学重点学科;050021 石家庄, 河北省疾病预防控制中心 河北省医学病毒学重点学科;050021 石家庄, 河北省疾病预防控制中心 河北省医学病毒学重点学科 |
| |
| 基金项目： | 河北省科技支撑计划(11276103D-11) |
| |
| 摘 要： | 目的 了解河北省HIV/AIDS的HAART效果。方法 以1989－2013年全省报告的4 148例HIV/AIDS进行研究, 对发现的HIV/AIDS定期随访、检测CD4+T淋巴细胞计数、登记死亡。自2003年开始, 对符合HAART条件的HIV/AIDS实施免费治疗。观察截止日期为2013年12月31日。结果 4 148例HIV/AIDS, 观察12 451.48人年, 全死因死亡968例, 死亡密度7.77/100人年, 其中接受HAART者死亡密度为2.87/100人年, 未接受HAART者死亡密度为16.58/100人年, 后者是前者的5.77倍。对1 894例AIDS, 自发病之日至观察截止日, 观察4 774.48人年, 全死因死亡581例, 死亡密度121.69/100人年, 其中参加HAART者死亡密度4.77/100人年, 未参加HAART者死亡密度125.92/100人年。CD4+T淋巴细胞计数<200 cells/mm3组的死亡密度由不接受HAART治疗的22.9/100人年降至接受HAART治疗的5.3/100人年。通过年度分析发现, 随着HIV/AIDS人群HAART覆盖率逐年提高, 人群的全死因死亡率逐年下降。HIV人群HAART覆盖率提高, 可降低未参加HAART的HIV感染者的死亡率。结论 进一步扩大抗病毒治疗覆盖面, 可有效减少HIV/AIDS的死亡。
|
| 关 键 词： | 艾滋病病毒感染/艾滋病患者 高效联合抗反转录病毒治疗 全死因死亡 死亡率 死亡密度 |
| 收稿时间： | 2014/11/8 0:00:00 |
Effect of highly active anti-retroviral therapy on reducing HIV/AIDS related death in Hebei, 1989-2013 |
| |
| Chen Suliang,Ma Lin,Lu Xinli,Li Yan,Wang Wei,Wang Yingying,Zhao Cuiying,Zhang Yuqi and Zhao Hongru.Effect of highly active anti-retroviral therapy on reducing HIV/AIDS related death in Hebei, 1989-2013[J].Chinese Journal of Epidemiology,2015,36(5):460-464. |
| |
| Authors: | Chen Suliang Ma Lin Lu Xinli Li Yan Wang Wei Wang Yingying Zhao Cuiying Zhang Yuqi and Zhao Hongru |
| |
| Affiliation: | Hebei Provincial Key Discipline of Medical Virology, Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang 050021, China;Hebei Provincial Key Discipline of Medical Virology, Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang 050021, China;Hebei Provincial Key Discipline of Medical Virology, Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang 050021, China;Hebei Provincial Key Discipline of Medical Virology, Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang 050021, China;Hebei Provincial Key Discipline of Medical Virology, Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang 050021, China;Hebei Provincial Key Discipline of Medical Virology, Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang 050021, China;Hebei Provincial Key Discipline of Medical Virology, Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang 050021, China;Hebei Provincial Key Discipline of Medical Virology, Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang 050021, China;Hebei Provincial Key Discipline of Medical Virology, Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang 050021, China |
| |
| Abstract: | Objective To investigate the effect of highly active anti-retroviral therapy (HAART) on reducing HIV/AIDS related death. Methods The analysis was conducted by using the data of 4 148 HIV/AIDS cases reported in Hebei province from 1989 to 2013. Regular follow-up, CD4 detection, registration of death were carried out for them. Free HAART has been provided to people living with HIV/AIDS who met the treatment requirement since 2003. Results Of 4 148 HIV/AIDS cases, 12 451.48 person years were observed, 968 cases died due to all registered death causes. The death density was 7.77/100 person years. The death density was 2.87/100 person years for the HIV/AIDS cases receiving HAART, and 16.58/100 for the HIV/AIDS cases receiving no HAART. In 1 894 AIDS cases, a total of 4 774.48 person years were observed from onset to death, 581 cases died due to all registered death causes, and the death density was 121.69/100 person years. The death density was 4.77/100 person years for the cases receiving HAART, and 125.92/100 person years for the cases receiving no HAART. In the cases with CD less than 200/mm3, the death density was 22.9/100 person years for those receiving no HAART and 5.3/100 person years for those receiving HAART. The annual analysis found that the death rate due to all registered death causes declined as the increase of HAART coverage in people living with HIV/AIDS. The expanding of HAART coverage in people infected with HIV can reduce death rate among them. Conclusion Further expanding of HAART can effectively reduce the death among people living with HIV/AIDS. |
| |
| Keywords: | HIV/AIDS Highly active anti-retrovial therapy All causes of death Mortality Death density |
|
| 点击此处可从《中华流行病学杂志》浏览原始摘要信息 |
|
点击此处可从《中华流行病学杂志》下载全文 |
|
